Cardiovascular Diabetology is a prestigious open-access journal published by BMC, focusing on the intersecting fields of cardiology, endocrinology, diabetes, and internal medicine. Since its inception in 2002, this journal has established itself as a vital resource for researchers, clinicians, and academics dedicated to advancing knowledge in these areas. With an impressive impact factor reflected in its Q1 rankings for the year 2023 across its respective categories, including a ranking of 22nd in Cardiology and Cardiovascular Medicine and notably 15th in Internal Medicine, it positions itself at the forefront of scholarly communication. The journal encourages the dissemination and sharing of groundbreaking research, providing open access to foster engagement and collaboration among professionals globally. As it converges from 2002 to 2024, Cardiovascular Diabetology continues to be a pivotal platform for innovative studies, reviews, and critical insights that significantly impact clinical practices and medical education in the evolving landscape of cardiovascular health and diabetes management.

The Journal fur Kardiologie, published by KRAUSE & PACHERNEGG GMBH, is a pivotal resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 1024-0098 and an E-ISSN of 1680-936X, this journal has played a significant role in disseminating valuable research and clinical studies from 1998 until its coverage discontinuation in Scopus in 2017. Despite its Scopus rank being relatively low at #316/324 in its category, it continues to serve as a platform for emerging cardiology research. The journal’s scope encompasses various aspects of cardiovascular health, providing insights that are crucial for researchers, professionals, and students alike seeking to advance their knowledge and practice in cardiology. While the journal is not open access, its contributions to the field are essential for those looking to stay informed about the latest developments in cardiovascular medicine.

ACTA CARDIOLOGICA is a distinguished journal published by TAYLOR & FRANCIS LTD, focusing on the dynamic fields of Cardiology and Cardiovascular Medicine. Established in 1946, the journal has maintained a significant presence in the academic community, providing a platform for cutting-edge research and clinical studies that aim to address challenges in cardiovascular health. With its Q3 rating in both Cardiology and General Medicine categories, it showcases a robust compilation of articles that reflect the evolving landscape of cardiac care. Although ACTA CARDIOLOGICA is not an Open Access journal, it continues to serve a vital role for researchers, professionals, and students dedicated to advancing knowledge in cardiovascular health. This journal, with an ISSN of 0001-5385 and E-ISSN of 1784-973X, is a critical resource for those looking to stay updated on the latest developments and practices in the specialization, contributing significantly to the field until 2024 and beyond.

TEXAS HEART INSTITUTE JOURNAL, published by the renowned Texas Heart Institute, stands as a pivotal resource in the field of cardiology and cardiovascular medicine. With a history spanning over four decades since its establishment in 1982, this journal addresses a wide range of topics within its scope, including clinical studies, innovative treatments, and groundbreaking research in heart health. Despite its Q3 ranking in both Cardiology and Cardiovascular Medicine, the journal is committed to fostering advancement in medical knowledge and practice, providing an essential platform for healthcare professionals and researchers alike. While currently lacking open access, the journal is recognized for its contributions to the field, aiming to illuminate critical healthcare discussions and promote the exchange of ideas. For those interested in staying at the forefront of cardiovascular research, TEXAS HEART INSTITUTE JOURNAL offers invaluable insights and the latest developments shaping the future of heart care.

Indian Heart Journal, published by Elsevier, is a distinguished peer-reviewed journal dedicated to the field of cardiology and cardiovascular medicine. Founded in 1961, this journal has been a pivotal resource for researchers, healthcare professionals, and students, providing a platform for innovative studies and insights into heart health. The journal transitioned to an Open Access model in 2013, ensuring widespread dissemination of vital research findings to enhance global understanding of cardiovascular diseases. Ranked in the Q3 category for Cardiology and Cardiovascular Medicine in 2023, it holds a reputable position in the medical community, with a Scopus rank of #222 out of 387 journals in the same field, placing it in the 42nd percentile. The Indian Heart Journal strives to foster advances in clinical practice and research while addressing the unique cardiac health challenges faced in India and beyond.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, published by Mosby-Elsevier, stands as a leading peer-reviewed journal dedicated to advancing the fields of thoracic and cardiovascular surgery. With an impressive impact factor reflecting its rigorous standards and significance, this journal occupies prestigious Q1 quartiles in 2023 across Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, as well as Surgery. Additionally, it boasts remarkable rankings in the Scopus database, being placed at #8 in Surgery and #29 in Cardiology and Cardiovascular Medicine, underscoring its pivotal role in disseminating high-quality research and clinical insights. Its scope encompasses vital areas such as surgical techniques, innovative therapies, and patient outcomes, making it an essential resource for researchers, clinicians, and students passionate about advancing cardiac and pulmonary health. Though not an open-access journal, it ensures that subscribers and institutional partners can access valuable research contributions published within its pages from 1959 to 2024. The JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY continues to shape the future of surgical practices and enhance patient care on a global scale.

JACC: Cardiovascular Interventions is a premier journal dedicated to the field of cardiology and cardiovascular medicine, published by Elsevier Science Inc. This esteemed journal, with an ISSN of 1936-8798 and an E-ISSN of 1876-7605, has established itself as a leading platform for disseminating cutting-edge research and advancements from 2008 to the present, and is projected to continue until 2024. Recognized for its rigorous peer-review process and high-quality content, JACC: Cardiovascular Interventions holds a prestigious Q1 ranking in both Cardiology and Cardiovascular Medicine as well as a Q1 ranking in the broader category of Medicine (Miscellaneous) as of 2023. With a Scopus rank of #25 out of 387 in its field, placing it in the 93rd percentile, the journal is a vital resource for researchers, healthcare professionals, and students alike. Although it does not currently offer open access, its essential contributions to the medical community underscore its importance in advancing cardiovascular intervention knowledge and practice.

Expert Review of Cardiovascular Therapy is a leading academic journal published by TAYLOR & FRANCIS INC, focusing on innovative and impactful research in the field of cardiovascular medicine. With an ISSN of 1477-9072 and an E-ISSN of 1744-8344, this journal serves as an essential resource for researchers, clinicians, and educators, offering a platform for the dissemination of critical advancements in cardiovascular therapy and internal medicine. Since its inception in 2003, the journal has maintained a reputable standing with a Q2 ranking in various categories including Cardiology and Cardiovascular Medicine, reflecting its influence and rigor in the field. The journal, which is based in the United Kingdom, does not currently offer Open Access options, ensuring that its content is accessible primarily to subscribers. With its commitment to high-quality, peer-reviewed articles, Expert Review of Cardiovascular Therapy is dedicated to bridging the gap between experimental research and clinical application, thereby enhancing patient care and therapeutic outcomes in cardiovascular health.

Postepy w Kardiologii Interwencyjnej is a prominent scholarly journal dedicated to the field of interventional cardiology, published by the esteemed TERMEDIA PUBLISHING HOUSE LTD. Since its transition to an Open Access model in 2005, this journal has provided a platform for the dissemination of valuable research and clinical insights, reaching a broad audience of researchers, healthcare professionals, and students in Poland and beyond. With an ISSN of 1734-9338 and E-ISSN of 1897-4295, the journal has established its relevance by featuring articles that are currently indexed in Scopus, reflecting its impact in the field, particularly with a rank of #269 out of 387 in the category of Cardiology and Cardiovascular Medicine for 2023. The publication has continuously evolved to meet the demands of the scientific community, making it an essential resource for staying informed about the latest advancements in interventional techniques and cardiology research. With its commitment to enhancing the knowledge base of cardiovascular medicine, Postepy w Kardiologii Interwencyjnej plays a critical role in fostering collaboration and innovation within this vital specialty.

Netherlands Heart Journal is a premier academic publication dedicated to advancing knowledge in the field of cardiology and cardiovascular medicine. Published by BOHN STAFLEU VAN LOGHUM BV, this journal has established itself as a critical platform for researchers, professionals, and students seeking to explore groundbreaking findings and innovative practices in cardiovascular health. With an ISSN of 1568-5888 and E-ISSN 1876-6250, the journal boasts a respectable Q2 ranking in the Cardiology and Cardiovascular Medicine category, placing it in the top half of its field according to the 2023 quartiles. The Scopus ranking places it 130th out of 387 in the relevant category, indicating a commendable percentile rank of 66th, which attests to its influence and quality of published research. Spanning from 2005 to 2024, the journal endeavors to include a diverse array of topics, encompassing clinical practice, technological innovations, and public health considerations related to cardiovascular diseases. Researchers and practitioners are encouraged to engage with the journal's robust content, contributing to and benefiting from the collaborative effort to enhance cardiovascular health worldwide.